23Indexed trials
mesh condition
Glioblastoma
Intelligence
Glioblastoma intelligence: 23 indexed trials, 4 recruiting studies, 21 sponsors across 14 countries.
4Recruiting
21Sponsors
14Countries
Leading sponsors
Annick Desjardins20 recruiting
Assistance Publique - Hôpitaux de Paris21 recruiting
Cortice Biosciences, Inc.10 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Duke University10 recruiting
INSYS Therapeutics Inc10 recruiting
Insel Gruppe AG, University Hospital Bern11 recruiting
Mayo Clinic11 recruiting
Medical University of Vienna10 recruiting
Memorial Sloan Kettering Cancer Center10 recruiting
National Cancer Institute (NCI)10 recruiting
National Neuroscience Institute10 recruiting
Geographic activity
United States11trials
Germany6trials
Switzerland4trials
Austria3trials
France3trials
United Kingdom2trials
Netherlands2trials
Singapore1trials
Spain1trials
Sweden1trials
Greece1trials
Israel1trials
Leading interventions
ACT0011trials
APG1011trials
AZD74511trials
Adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist1trials
Alectinib1trials
Atezolizumab1trials
Bevacizumab1trials
Cerebral open flow microperfusion1trials
Concomitant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist1trials
Enhanced Usual Care / EUC1trials
Focus Group1trials
5-ALA1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.